Amdocs (DOX) Projected to Post Quarterly Earnings on Tuesday

Amdocs (NASDAQ:DOX) will likely be announcing its Q4 2025 results after the market closes on Tuesday, November 11th. Analysts expect Amdocs to post earnings of $1.82 per share and revenue of $1.1460 billion for the quarter. Investors can check the company’s upcoming Q4 2025 earningsummary page for the latest details on the call scheduled for Wednesday, November 12, 2025 at 7:00 AM ET.

Amdocs (NASDAQ:DOX) last issued its quarterly earnings data on Wednesday, August 6th. The technology company reported $1.72 earnings per share for the quarter, beating analysts’ consensus estimates of $1.71 by $0.01. The business had revenue of $1.14 billion during the quarter, compared to analysts’ expectations of $1.13 billion. Amdocs had a return on equity of 19.66% and a net margin of 11.94%.The company’s revenue was down 8.4% on a year-over-year basis. During the same period in the previous year, the firm posted $1.62 earnings per share. On average, analysts expect Amdocs to post $6 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Amdocs Trading Up 0.4%

Shares of DOX stock traded up $0.31 on Tuesday, hitting $84.44. The stock had a trading volume of 55,056 shares, compared to its average volume of 749,342. The company’s 50 day moving average price is $83.66 and its 200-day moving average price is $87.48. Amdocs has a 1 year low of $78.61 and a 1 year high of $95.41. The firm has a market capitalization of $9.53 billion, a P/E ratio of 17.07, a P/E/G ratio of 1.40 and a beta of 0.51. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.22 and a quick ratio of 1.22.

Amdocs Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, October 31st. Stockholders of record on Tuesday, September 30th were given a dividend of $0.527 per share. This represents a $2.11 annualized dividend and a dividend yield of 2.5%. The ex-dividend date of this dividend was Tuesday, September 30th. Amdocs’s dividend payout ratio is currently 42.60%.

Institutional Investors Weigh In On Amdocs

A number of hedge funds and other institutional investors have recently modified their holdings of DOX. Amundi grew its stake in shares of Amdocs by 73.0% during the first quarter. Amundi now owns 13,778 shares of the technology company’s stock worth $1,217,000 after purchasing an additional 5,816 shares in the last quarter. Millennium Management LLC raised its stake in Amdocs by 458.3% in the first quarter. Millennium Management LLC now owns 67,047 shares of the technology company’s stock valued at $6,135,000 after buying an additional 55,038 shares in the last quarter. Goldman Sachs Group Inc. lifted its holdings in Amdocs by 12.6% during the 1st quarter. Goldman Sachs Group Inc. now owns 331,146 shares of the technology company’s stock worth $30,300,000 after buying an additional 37,087 shares during the last quarter. Empowered Funds LLC boosted its position in shares of Amdocs by 12.0% during the 1st quarter. Empowered Funds LLC now owns 15,979 shares of the technology company’s stock worth $1,462,000 after acquiring an additional 1,709 shares in the last quarter. Finally, Jane Street Group LLC boosted its position in shares of Amdocs by 195.4% during the 1st quarter. Jane Street Group LLC now owns 115,929 shares of the technology company’s stock worth $10,608,000 after acquiring an additional 76,683 shares in the last quarter. 92.02% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the stock. Weiss Ratings restated a “hold (c)” rating on shares of Amdocs in a report on Thursday, October 30th. Wolfe Research began coverage on shares of Amdocs in a research note on Tuesday, July 8th. They issued an “outperform” rating for the company. Finally, Wall Street Zen upgraded Amdocs from a “hold” rating to a “buy” rating in a report on Saturday, October 11th. Three research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $108.00.

About Amdocs

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.